COCRYSTAL PHARMA, INC. Repayments of Debt
COCRYSTAL PHARMA, INC. (COCP) reported Repayments of Debt of $217.55 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2013-11-18
- COCRYSTAL PHARMA, INC. repayments of debt for the quarter ending 2013-09-30 was $137.42K, a 114.62% increase year-over-year.
- COCRYSTAL PHARMA, INC. repayments of debt for the quarter ending 2013-06-30 was $55.07K.
- COCRYSTAL PHARMA, INC. repayments of debt for the quarter ending 2013-03-31 was $25.07K.
- COCRYSTAL PHARMA, INC. repayments of debt for the quarter ending 2012-12-31 was $31.41K.
- COCRYSTAL PHARMA, INC. repayments of debt for fiscal 2012 was $222.00K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 9 month as first filed | Repayments of Debt 12 month |
|---|---|---|---|---|---|
| 2013-09-30 | $137.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | $192.48K derived: sum of 2 quarters · filed 2013-11-18 | $217.55K 10-Q · filed 2013-11-18 | $248.96K derived: sum of 4 quarters · filed 2013-11-18 | |
| 2013-06-30 | $55.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $80.13K 10-Q · filed 2013-08-15 | $111.54K derived: sum of 3 quarters · filed 2013-08-15 | $175.57K derived: sum of 4 quarters · filed 2013-11-18 | |
| 2013-03-31 | $25.07K 10-Q · filed 2013-05-10 | $56.47K derived: sum of 2 quarters · filed 2013-05-10 | $120.50K derived: sum of 3 quarters · filed 2013-11-18 | ||
| 2012-12-31 | $31.41K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $95.44K derived: sum of 2 quarters · filed 2013-11-18 | $222.00K 10-K · filed 2013-04-01 | ||
| 2012-09-30 | $64.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-18 | $190.59K 10-Q · filed 2013-11-18 | -$190.59K 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $126.56K 10-Q · filed 2013-08-15 | ||||
| 2011-09-30 | -$2.45M 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |